|
BRD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.915000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.771010E-01 |
| Normal-vs-Stage2 |
5.271200E-01 |
| Normal-vs-Stage3 |
1.236570E-01 |
| Normal-vs-Stage4 |
3.67669999999931E-05 |
| Stage1-vs-Stage2 |
8.732200E-01 |
| Stage1-vs-Stage3 |
5.322400E-01 |
| Stage1-vs-Stage4 |
6.41279999999966E-05 |
| Stage2-vs-Stage3 |
5.337200E-01 |
| Stage2-vs-Stage4 |
3.958200E-03 |
| Stage3-vs-Stage4 |
8.463500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.253400E-01 |
| Normal-vs-AfricanAmerican |
1.882180E-01 |
| Normal-vs-Asian |
6.519800E-03 |
| Caucasian-vs-AfricanAmerican |
5.057200E-01 |
| Caucasian-vs-Asian |
3.937600E-03 |
| AfricanAmerican-vs-Asian |
1.153630E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.384600E-01 |
| Normal-vs-Female |
7.241400E-01 |
| Male-vs-Female |
7.206800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.852500E-02 |
| Normal-vs-Extreme_Weight |
2.732800E-01 |
| Normal-vs-Obese |
8.560000E-01 |
| Normal-vs-Extreme_Obese |
8.988300E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.976400E-01 |
| Normal_Weight-vs-Obese |
7.106200E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.714400E-01 |
| Extreme_Weight-vs-Obese |
4.072200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.746000E-01 |
| Obese-vs-Extreme_Obese |
2.821000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.440200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.981000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.332560E-01 |
| Normal-vs-Age(81-100Yrs) |
8.630400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.055200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.719400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.100190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.530400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.026300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.007200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.985790E-01 |
| Normal-VS-Type2 PRCC |
2.31829999641775E-08 |
| Normal-VS-KIRP CIMP |
7.205800E-02 |
| Normal-VS-Unclassified PRCC |
7.905400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.66533453693773E-15 |
| Type1 PRCC-VS-KIRP CIMP |
8.925700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.531400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.458300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.642610E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
2.895800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.006200E-02 |
| Normal-vs-N1 |
9.052100E-02 |
| Normal-vs-N2 |
2.507900E-02 |
| N0-vs-N1 |
5.902000E-01 |
| N0-vs-N2 |
4.837800E-01 |
| N1-vs-N2 |
3.618200E-01 |
|
|
